cisatracurium has been researched along with Ovarian Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, W; Jiang, Y; Shi, C; Wang, X; Zhu, D; Zhu, K | 1 |
1 other study(ies) available for cisatracurium and Ovarian Neoplasms
| Article | Year |
|---|---|
Cisatracurium inhibits the growth and induces apoptosis of ovarian cancer cells by promoting lincRNA-p21.
Topics: Apoptosis; Atracurium; Cell Line, Tumor; Cell Proliferation; Female; Humans; Ovarian Neoplasms; RNA, Long Noncoding | 2021 |